An Australian multi-centre experience of the use of peptide receptor radionuclide therapy for bronchial carcinoid tumours

被引：0

作者：

Lim, L. E. ^{[1
]}

Chan, D. L. ^{[2
]}

Thomas, D. ^{[3
]}

Wyld, D. K. ^{[4
]}

Cehic, G. ^{[5
]}

Macdonald, W. ^{[6
]}

Du, Y. T. ^{[5
]}

Tincknell, G. ^{[3
]}

Kuchel, A. ^{[4
]}

Pavlakis, N. ^{[2
]}

Bailey, D. ^{[2
]}

Davis, A. ^{[2
]}

Segelov, E. ^{[1
]}

机构：

[1] Monash Hlth, Med Oncol, Melbourne, Vic, Australia

[2] Royal North Shore Hosp, Med Oncol, St Leonards, NSW, Australia

[3] St George Hosp, Med Oncol, Kogarah, NSW, Australia

[4] Royal Brisbane & Womens Hosp, Med Oncol, Herston, Qld, Australia

[5] Queen Elizabeth Hosp, Nucl Med, Woodville South, SA, Australia

[6] Fiona Stanley Hosp, Nucl Med, Murdoch, WA, Australia

来源：

ANNALS OF ONCOLOGY | 2019年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1401P

引用

页码：572 / 572

页数：1

共 50 条

[1] Peptide receptor radionuclide therapy for metastatic bronchopulmonary carcinoid tumours: a single ENETS Centre of Excellence experience
Evans, J.
Yang, W. M.
Newsom-Davis, T.
Sharma, R.
[J]. LUNG CANCER, 2019, 127 : S59 - S59
[2] Peptide Receptor Radionuclide Therapy In Broncopulmonary Neuroendocrine Tumours - Results Of A Single Centre Experience
Ferreira, G.
Castro, S.
Costa, C.
Violante, L.
Teixeira, J.
Duarte, H.
Sampaio, I. L.
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S89 - S89
[3] Efficacy of Peptide Receptor Radionuclide Therapy in Patients with Advanced Bronchial Neuroendocrine Tumours
Koffas, A.
Popat, R.
Mohmaduvesh, M.
Quigley, A. M.
Navalkissoor, S.
Caplin, M.
Toumpanakis, C.
[J]. NEUROENDOCRINOLOGY, 2016, 103 : 81 - 81
[4] Peptide receptor radionuclide therapy with 177Lu-octreotate in foregut carcinoid tumours
Van Essen, M.
Krenning, E. P.
Bakker, W. H.
Kooij, P. P.
Kwekkeboom, D. J.
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S215 - S215
[5] Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin
Martijn van Essen
Eric P. Krenning
Willem H. Bakker
Wouter W. de Herder
Maarten O. van Aken
Dik J. Kwekkeboom
[J]. European Journal of Nuclear Medicine and Molecular Imaging, 2007, 34 : 1219 - 1227
[6] Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin
van Essen, Martijn
Krenning, Eric P.
Bakker, Willem H.
de Herder, Wouter W.
van Aken, Maarten O.
Kwekkeboom, Dik J.
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (08) : 1219 - 1227
[7] Peptide receptor radionuclide therapy of neuroendocrine tumours
Bodei, L.
Giammarile, F.
[J]. MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2009, 33 (03): : 142 - 147
[8] Peptide receptor radionuclide therapy of neuroendocrine tumours
Brabander, Tessa
Teunissen, Jaap J. M.
Van Eijck, Casper H. J.
Franssen, Gaston J. H.
Feelders, Richard A.
de Herder, Wouter W.
Kwekkeboom, Dik J.
[J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 30 (01) : 103 - 114
[9] Peptide receptor radionuclide therapy for neuroendocrine tumours
Siraj Yusuf
Shahad Alsadik
Adil AL-Nahhas
[J]. Clinical and Translational Imaging, 2018, 6 : 101 - 111
[10] PEPTIDE RECEPTOR RADIONUCLIDE THERAPY OF NEUROENDOCRINE TUMOURS
Bodei, L.
Grana, C. M.
Cremonesi, M.
Paganelli, G.
[J]. ANNALS OF ONCOLOGY, 2012, 23 : 47 - 47

← 1 2 3 4 5 →